pre-miRNA Information
pre-miRNA hsa-mir-210   
Genomic Coordinates chr11: 568089 - 568198
Synonyms MIRN210, mir-210, MIR210
Description Homo sapiens miR-210 stem-loop
Comment This human miRNA was predicted by computational methods using conservation with mouse and Fugu rubripes sequences .
RNA Secondary Structure
Associated Diseases

Mature miRNA Information
Mature miRNA hsa-miR-210-3p
Sequence 66| CUGUGCGUGUGACAGCGGCUGA |87
Evidence Experimental
Experiments Cloned
Editing Events in miRNAs
Modification Type Position on miR Chromosome DNA Strand Genomic Position (hg38) List of PMIDs Variant details
A-to-I 12 11 - 568122 25582055 MiREDiBase
A-to-I 14 11 - 568120 26028588 MiREDiBase
C-to-U 1 11 - 568133 26209130 MiREDiBase
SNPs in miRNA
Mutant ID Mutant Position Mutant Source
rs753825152 1 dbSNP
rs759616365 3 dbSNP
rs1247955373 6 dbSNP
rs558661304 9 dbSNP
rs1490451308 13 dbSNP
rs1344162213 14 dbSNP
rs745930382 15 dbSNP
rs1220183952 16 dbSNP
rs1355496181 17 dbSNP
rs1280245998 19 dbSNP
rs781628850 20 dbSNP
rs1241231800 22 dbSNP
Putative Targets

miRNA Expression profile
Human miRNA Tissue Atlas
miRNAs in Extracellular Vesicles
Circulating MicroRNA Expression Profiling
Biomarker Information
Biomarker ID Name Type Discovered From Mode Level Source Testing Methods
BX0CY6 miR-210 Predictive Biomarker (PRD); Safety Biomarker (SAF) Clinical/Experimental Data Expression Increase Urine Quantitative real-time reverse transcription PCR
BX0CY6 miR-210 Predictive Biomarker (PRD); Safety Biomarker (SAF) Clinical/Experimental Data Expression Low Blood Reverse transcription-polymerase chain reaction
Gene Information
Gene Symbol DDAH1   
Synonyms DDAH, DDAH-1, DDAHI, HEL-S-16
Description dimethylarginine dimethylaminohydrolase 1
Transcript NM_001134445   
Other Transcripts NM_012137   
Expression
Putative miRNA Targets on DDAH1
3'UTR of DDAH1
(miRNA target sites are highlighted)
>DDAH1|NM_001134445|3'UTR
   1 GCTGCAGAGTCCCCCCCGGTAGCCGGCAAGACCGCACAGGCAAGGCCGATGACTCTGTGCCCACTCCTGTTGTTTTCCTT
  81 GACAATCTACTGTGCCACTGTGCTACTAACTCTTGTTTACAAAATTTGATTCTAAGTTGAATTGCTTCATTCAACACCCC
 161 CACCCTCCCTCCCCTCGAGGTGGTACCTAAGCTGTGGATTTGCTAAATGAATTAAGCAACCTAGAAGATACAGAGCTAAT
 241 GAATTATCAAAATGTGATTAATCCCAGTAAGGAAACACTCATTTAGTGTCTGTATTTTTGGTGTGAAAATTATTTAGTTG
 321 CCAGTATATTCTGAAGAATGTCTTCTTGATCAGTCAGATAAGCTTGCTTTTTTTTTTTTTTTTTTTCATGAATCATGTTT
 401 GGTTCCTGTGAAAGTCCCTGGTCCAGGGATCCTCCTCCTTTCTCTTTTACTTCTGAATTCTGAAATTCAGTTAGTTACTT
 481 TTGCCTTTCGCTCTTCTATCACAGCCACCTTGACCTTGGGTAAAACCCAAGGTCTTTCCTTCTGGCTACCTTCCTGCAGG
 561 TCCACCCTGTCTGCCATTGGTCTCCTCTGCCTCTGACTACATCTGCCACCAACAACCCTCCCCTCACCCCTGCCAGGGGC
 641 AGACAGGCTTCTCAGCAGAACTGTGACTGAAATCAGAGCTGCTGTCTGGGGCAGTGTTAACTACACAGAGGCACATCCTG
 721 ACAGGGTTTGCCCCAGAGATCTAAATTCCAGAAGGAGGGCACCACACCTAGGAAGGTAAATCCAGTATCAGAAGGTTGCT
 801 AAAAGATTAAAGATCAAGAAGCTTGGAAACATCCCATGGGTACAATGTCTTAGAAAGTCTTTAAGTCACATACCATGAAT
 881 TTTTGCTTCATTACTGACCATATATGACCTTGGAGGAACTCTTTTTTTTTTTTCCTTCTACTCATTTCTGTTTCCACCTA
 961 CCCTGACTCACCGTATTTCCAGTCTTCTACCCCTGCAGTTATCCTAGTCCAGCAAAGTCATTTCTTTCAAAAGAGACATC
1041 ATGTCTGAAAATAATTACTGGTAGTCTAATATGAGCCAGAGTAAACAGCTCCTCATGGTCAATGAACATGTTCAGGAAGC
1121 GATCACCTTGATGCTTGAACCCAACCCCAGACAGTGGACAATTCTACTTTGAAATATCCGTGAATATTTACTGTGGGATC
1201 CAATTTAAACTTCTTTCTTCTCTAGCCTTTAAATTACACAACTTTGAACTGACACGGATCTCTTACAAAGAACAATGCGG
1281 CACTGAAGGAAGAGATGATTCCTTTACTCAAACCTGCAGGAATCAGCCTATTAACAGGCAGGGGAAACGGTACTTTCCAA
1361 TGAATGGTAACTGATCCAGGCACATTATCACACTTCCTAGTCATCTCCACCTTTCCTGTATTGCCTGTGGCTTGTTGTTT
1441 AAGATTAAGAATCAAAGAGATTAAGAAGTATCACTTCAAATCTTGCTCTGCTCACTTCTATGTTTGCAGTCAAATTATTC
1521 CTTATGTTGGTGACCTAAAGAGAATTACTTTCATTCATTTCATTTCCCCCGTAGCAGATGGAAGGAGAAACCTCTGAGAA
1601 AATGAAAACATCCTTAACCACTATCTTTCCCTTTTATTTGATTATTTTATGTCAGAAATTTGCAAAAGTTTTTTTCTCCT
1681 CCTTCTCTTCCTTGTTGCTTAACTTTTTAATTCATGCCATATGCAGATATCCAATTATGTGCATCCTGTGAATAAACCAC
1761 GTCTTGGTCACTGTCATATTTTGAACCATCTCATCAGAGATGAATAATATCTTTTTACCAGAGAGAGAACGAATGTTAGC
1841 CACATGCCCAAGTTAACAAAGAAAAAATGTTCTCAAGGTTGTCCTTTTGGGTTAAATCTGGCCCTTCCTTGGCAAAAGCA
1921 AAAATTCTCCCTGTGAGAGCTCAACATCTCAAATACAACCACAGGAAAAATGGCCCAATCTGCCAGTTTAGGCTTACCAG
2001 CATATAATTTTTAATATCTTTACTTCTATCATCCCAAATCAAAGAACTCTTCTCTATTATGTTTAATCAATTGCAAGCAA
2081 ATAGATTTTTCTTTGTAACAATTTGTTCTGCAGAAGGCTGTTTTTCACTTTTCCTTTCTTTTGCTTCTTTCTGTCTTTCC
2161 TTCTCTTTTGTCTGGAGAAATCACTTAGACTCTGTGTGCCTCTTCTACATTGCATTCTGCTCTGCTATGTTACCTGCTAG
2241 GCTGGCTTCTTTGGACTCCCTATATGATTGATGATGTGAAAACCTAAATTACTTGCAGCATAGTATTACTTCTTTGATGT
2321 TCTCATTAGCATAATGTTATTTTTGAAAAGGAAAGATACTATCACATAAGTTTTCCTCATCTGTTGTGATATACACCAAT
2401 GGATAAACTAACGGAAACTGCTTTTTGACATTAAAAGACAGGAGAAATTATATTTAACTAAGTAAAAGTTAAGTCAGAAT
2481 TACTTGGGTGATGTGATTCAATTTAGTTAAAGGATGATATAGAGAAAATACATTATTTAGCATTATTTCTTCAGCTATAA
2561 TGAATTGCTATAGAAATCAGGCAGATCTTTCTAATGTGTATTGATTGGTCTTTTCAGCTACTCTGAACAGATTACTAAGG
2641 CCATCTCCTCATCTCTAAGGGAGAAAAATAGTCTGTAGATGAATAATGTAAGGTAAAGAGTTGCATGTCAGTCTTTGTAA
2721 TTATTTACACTTTAACTTTCTCCAGAACTCAGACATGATTTCAACATGGTGTTAGATTTGTGCATTTTATTTTCCTGACC
2801 ACCTCATTCCAGCCAATGTATGGTTATCCACTCTGTGTGCCAAAACCAATCATGCCTTTCACGGCCCTTTAGTTCAGAGA
2881 AGTTCTGCACTGATTTTTAGTCTCTTGATGTCTCAATCTTACATGTATACCAATCACAATGGAATAAAGTGTTGAGTTGT
2961 ACTGTGAAAAAA
Target sites Provided by authors   Predicted by miRanda    DRVs    SNPs    DRVs & SNPs
miRNA-target interactions
(Predicted by miRanda)
ID Duplex structure Position Score MFE
1
miRNA  3' agUCGGCGACAGUGU-GCGUGUc 5'
            |||||  |  | | |||||| 
Target 5' gtAGCCG--GCAAGACCGCACAg 3'
19 - 39 124.00 -22.20
2
miRNA  3' agUCGGCGACAGUGUGCGUGUc 5'
            :|:  ||| : || ||||| 
Target 5' atGGTAACTGATCCAGGCACAt 3'
1364 - 1385 124.00 -12.30
3
miRNA  3' agucggcgacaGUGUGCGUGUc 5'
                     || | ||||| 
Target 5' tgttaactacaCAGAGGCACAt 3'
695 - 716 115.00 -8.60
DRVs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
COSN30548392 2 COSMIC
COSN30522755 7 COSMIC
COSN28873996 10 COSMIC
COSN30506303 10 COSMIC
COSN15323990 11 COSMIC
COSN30653504 11 COSMIC
COSN31495014 13 COSMIC
COSN8407166 17 COSMIC
COSN10055190 24 COSMIC
COSN13563706 34 COSMIC
COSN30468884 81 COSMIC
COSN30106704 128 COSMIC
COSN30191109 159 COSMIC
COSN8512225 234 COSMIC
COSN18723352 367 COSMIC
COSN27226634 368 COSMIC
COSN19030441 626 COSMIC
COSN6048628 707 COSMIC
COSN21948328 865 COSMIC
COSN29009639 921 COSMIC
COSN20094989 922 COSMIC
COSN6471348 969 COSMIC
COSN20090272 1120 COSMIC
COSN31540738 1178 COSMIC
COSN31588793 1179 COSMIC
COSN20094983 1584 COSMIC
COSN28201921 1810 COSMIC
COSN22218226 2014 COSMIC
COSN32063875 2049 COSMIC
COSN32063020 2199 COSMIC
COSN23014441 2698 COSMIC
COSN30169345 2863 COSMIC
COSN31550030 2871 COSMIC
rs233115 158 GWAS
rs1498373 1384 GWAS
rs233111 1384 GWAS
rs233112 1384 GWAS
rs233118 1384 GWAS
SNPs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
rs752314840 8 dbSNP
rs1327870147 9 dbSNP
rs116870917 11 dbSNP
rs199952327 15 dbSNP
rs575672231 16 dbSNP
rs3087894 17 dbSNP
rs376128434 18 dbSNP
rs772391520 18 dbSNP
rs779212403 18 dbSNP
rs1172711726 20 dbSNP
rs763169081 20 dbSNP
rs233116 21 dbSNP
rs779098725 22 dbSNP
rs1453571287 23 dbSNP
rs370850374 24 dbSNP
rs376027711 25 dbSNP
rs372032069 29 dbSNP
rs372729975 33 dbSNP
rs370768522 34 dbSNP
rs1164629653 37 dbSNP
rs536924149 38 dbSNP
rs776771057 47 dbSNP
rs376108439 48 dbSNP
rs1019325316 49 dbSNP
rs757596474 49 dbSNP
rs1256117650 50 dbSNP
rs1464203814 51 dbSNP
rs1480018127 55 dbSNP
rs1174913124 60 dbSNP
rs567883244 62 dbSNP
rs1239939591 66 dbSNP
rs1440191904 73 dbSNP
rs1192794532 77 dbSNP
rs1374218622 78 dbSNP
rs1169099154 85 dbSNP
rs1170085756 101 dbSNP
rs1022891791 104 dbSNP
rs1426270433 114 dbSNP
rs1009247443 116 dbSNP
rs1426773628 120 dbSNP
rs1401705115 131 dbSNP
rs557288131 140 dbSNP
rs1301760332 145 dbSNP
rs1373608484 146 dbSNP
rs12045545 154 dbSNP
rs233115 158 dbSNP
rs1056372483 159 dbSNP
rs1458195111 162 dbSNP
rs939382749 162 dbSNP
rs1200366449 164 dbSNP
rs1480914508 166 dbSNP
rs905109658 168 dbSNP
rs148775333 176 dbSNP
rs1191498366 177 dbSNP
rs233114 178 dbSNP
rs920412330 180 dbSNP
rs1424401949 183 dbSNP
rs1303599356 188 dbSNP
rs1235322173 189 dbSNP
rs367875656 190 dbSNP
rs1301702715 192 dbSNP
rs1045108413 198 dbSNP
rs1397811024 231 dbSNP
rs972328787 239 dbSNP
rs949507920 246 dbSNP
rs566124722 254 dbSNP
rs896481291 288 dbSNP
rs546515140 289 dbSNP
rs940405782 291 dbSNP
rs1360392417 295 dbSNP
rs199820774 300 dbSNP
rs1232657644 301 dbSNP
rs1036286199 303 dbSNP
rs1453192289 308 dbSNP
rs1222073828 313 dbSNP
rs529956005 323 dbSNP
rs1241257614 326 dbSNP
rs1485044954 343 dbSNP
rs1453407602 345 dbSNP
rs1054529 362 dbSNP
rs1180239506 363 dbSNP
rs911675199 366 dbSNP
rs1419503301 367 dbSNP
rs1249668233 368 dbSNP
rs1474928739 368 dbSNP
rs1194033609 373 dbSNP
rs987128152 378 dbSNP
rs940690478 386 dbSNP
rs1158898118 387 dbSNP
rs1268745435 387 dbSNP
rs1281887978 387 dbSNP
rs1299633254 387 dbSNP
rs1397819555 387 dbSNP
rs1406408909 387 dbSNP
rs1453821587 387 dbSNP
rs550307646 387 dbSNP
rs1029076853 388 dbSNP
rs1228798180 388 dbSNP
rs1215918272 390 dbSNP
rs1282551700 395 dbSNP
rs1287017181 396 dbSNP
rs1485444296 402 dbSNP
rs975654952 413 dbSNP
rs909441570 414 dbSNP
rs374997556 418 dbSNP
rs1239261796 420 dbSNP
rs527400026 421 dbSNP
rs1473434025 424 dbSNP
rs1177129953 425 dbSNP
rs1406310236 428 dbSNP
rs561209012 436 dbSNP
rs932152382 437 dbSNP
rs968715520 441 dbSNP
rs1360808402 444 dbSNP
rs1022438511 446 dbSNP
rs544083378 448 dbSNP
rs528649210 449 dbSNP
rs746325947 466 dbSNP
rs1278871121 470 dbSNP
rs779575046 477 dbSNP
rs975152893 478 dbSNP
rs1242089822 480 dbSNP
rs1035100922 485 dbSNP
rs1003587054 486 dbSNP
rs965091228 489 dbSNP
rs1019379417 490 dbSNP
rs987785618 493 dbSNP
rs956588138 500 dbSNP
rs1045485549 508 dbSNP
rs1032248312 511 dbSNP
rs994741595 513 dbSNP
rs200183871 516 dbSNP
rs1001212510 530 dbSNP
rs771354556 531 dbSNP
rs1394837943 535 dbSNP
rs1453465039 545 dbSNP
rs1170442332 556 dbSNP
rs1023456031 561 dbSNP
rs1403794900 565 dbSNP
rs1414557506 567 dbSNP
rs1327555023 572 dbSNP
rs899103467 587 dbSNP
rs1036187694 588 dbSNP
rs530693425 593 dbSNP
rs372380318 607 dbSNP
rs1306830234 613 dbSNP
rs1276838328 616 dbSNP
rs896535039 627 dbSNP
rs1256188254 629 dbSNP
rs545515528 636 dbSNP
rs1312951206 638 dbSNP
rs940672248 640 dbSNP
rs931725879 647 dbSNP
rs191501528 652 dbSNP
rs887798924 654 dbSNP
rs1379038652 655 dbSNP
rs1478123639 658 dbSNP
rs1166859572 659 dbSNP
rs1420793439 665 dbSNP
rs921583376 674 dbSNP
rs1331937923 681 dbSNP
rs1393561995 704 dbSNP
rs1384862783 705 dbSNP
rs1325241270 708 dbSNP
rs149648264 717 dbSNP
rs1276434126 718 dbSNP
rs932259619 725 dbSNP
rs968309955 730 dbSNP
rs1363027596 731 dbSNP
rs1179473470 748 dbSNP
rs1354780111 754 dbSNP
rs571382688 756 dbSNP
rs1258189472 757 dbSNP
rs1268467440 759 dbSNP
rs1188721590 767 dbSNP
rs551304777 772 dbSNP
rs956907994 776 dbSNP
rs755772093 781 dbSNP
rs11550406 782 dbSNP
rs1189369978 794 dbSNP
rs1278410905 797 dbSNP
rs1478523147 798 dbSNP
rs1003554469 827 dbSNP
rs233113 836 dbSNP
rs1456287674 837 dbSNP
rs1023620152 851 dbSNP
rs188229542 853 dbSNP
rs1260492778 863 dbSNP
rs912288029 868 dbSNP
rs988326557 869 dbSNP
rs575942318 877 dbSNP
rs1036322036 878 dbSNP
rs1004804517 889 dbSNP
rs890258740 899 dbSNP
rs1051608488 900 dbSNP
rs137891183 901 dbSNP
rs11809833 902 dbSNP
rs1214827906 903 dbSNP
rs1283440529 905 dbSNP
rs1489041819 905 dbSNP
rs1353051507 909 dbSNP
rs1254847430 919 dbSNP
rs1422029172 920 dbSNP
rs11811309 922 dbSNP
rs367621543 922 dbSNP
rs1491064465 923 dbSNP
rs947074929 923 dbSNP
rs1382427778 925 dbSNP
rs547166940 929 dbSNP
rs1156564786 933 dbSNP
rs1362726182 934 dbSNP
rs1398364081 934 dbSNP
rs370884327 934 dbSNP
rs531792937 934 dbSNP
rs796352010 934 dbSNP
rs1459294956 935 dbSNP
rs1238464468 936 dbSNP
rs1418426980 938 dbSNP
rs1164164163 940 dbSNP
rs1474883632 941 dbSNP
rs1255507846 943 dbSNP
rs1216852547 955 dbSNP
rs988319174 956 dbSNP
rs1481983707 959 dbSNP
rs1201616656 965 dbSNP
rs3813600 969 dbSNP
rs928112417 972 dbSNP
rs982268951 973 dbSNP
rs1381901747 986 dbSNP
rs1440617885 987 dbSNP
rs1175608991 988 dbSNP
rs1357581773 991 dbSNP
rs754541588 992 dbSNP
rs1303456746 1010 dbSNP
rs1396434243 1024 dbSNP
rs1024175781 1028 dbSNP
rs190938715 1031 dbSNP
rs1005416994 1041 dbSNP
rs887776812 1043 dbSNP
rs1300184917 1051 dbSNP
rs1470123024 1066 dbSNP
rs773650046 1073 dbSNP
rs1049499667 1075 dbSNP
rs1234824585 1076 dbSNP
rs996195902 1080 dbSNP
rs900733446 1087 dbSNP
rs1196666981 1090 dbSNP
rs1239838912 1091 dbSNP
rs1014939930 1094 dbSNP
rs186597126 1096 dbSNP
rs1190343062 1102 dbSNP
rs1004773399 1104 dbSNP
rs536200596 1117 dbSNP
rs543399189 1120 dbSNP
rs996440270 1121 dbSNP
rs913428231 1126 dbSNP
rs1464583938 1145 dbSNP
rs1173444677 1147 dbSNP
rs1271430217 1153 dbSNP
rs1052185456 1166 dbSNP
rs180855215 1170 dbSNP
rs766312428 1177 dbSNP
rs891433973 1180 dbSNP
rs1316732991 1188 dbSNP
rs1216188453 1200 dbSNP
rs767893345 1203 dbSNP
rs979467821 1205 dbSNP
rs1244739219 1227 dbSNP
rs1489613939 1241 dbSNP
rs928251141 1254 dbSNP
rs969043829 1255 dbSNP
rs916468999 1256 dbSNP
rs1459795165 1266 dbSNP
rs992065822 1266 dbSNP
rs948261972 1267 dbSNP
rs1425769006 1270 dbSNP
rs1169693543 1272 dbSNP
rs960526080 1275 dbSNP
rs1015206271 1278 dbSNP
rs1459172309 1279 dbSNP
rs963504814 1284 dbSNP
rs530663471 1286 dbSNP
rs867542724 1290 dbSNP
rs1397622471 1313 dbSNP
rs983472531 1314 dbSNP
rs750263964 1316 dbSNP
rs954596614 1319 dbSNP
rs565053835 1320 dbSNP
rs1323274440 1342 dbSNP
rs1027759587 1344 dbSNP
rs376049818 1345 dbSNP
rs1030287065 1348 dbSNP
rs1285588797 1349 dbSNP
rs1487408444 1350 dbSNP
rs1213535832 1354 dbSNP
rs900535385 1356 dbSNP
rs551939892 1357 dbSNP
rs1180609682 1372 dbSNP
rs996020835 1375 dbSNP
rs900292644 1376 dbSNP
rs1021472318 1379 dbSNP
rs233112 1384 dbSNP
rs1338217133 1388 dbSNP
rs891959428 1396 dbSNP
rs1417454541 1402 dbSNP
rs1267979547 1406 dbSNP
rs1236060943 1407 dbSNP
rs1447279255 1410 dbSNP
rs1282373870 1413 dbSNP
rs891569894 1414 dbSNP
rs1302406305 1426 dbSNP
rs1308197379 1437 dbSNP
rs1438491690 1451 dbSNP
rs1351846928 1453 dbSNP
rs376783777 1454 dbSNP
rs936184006 1455 dbSNP
rs559856171 1457 dbSNP
rs543046031 1458 dbSNP
rs938386109 1459 dbSNP
rs906794029 1462 dbSNP
rs1178459437 1468 dbSNP
rs1473382338 1468 dbSNP
rs760764797 1470 dbSNP
rs1437505004 1476 dbSNP
rs924999818 1479 dbSNP
rs233111 1480 dbSNP
rs1413418590 1483 dbSNP
rs1331582043 1485 dbSNP
rs1410561031 1486 dbSNP
rs1395867232 1495 dbSNP
rs948339871 1498 dbSNP
rs916705153 1500 dbSNP
rs1455745683 1501 dbSNP
rs1241975329 1502 dbSNP
rs1280361468 1523 dbSNP
rs947710734 1525 dbSNP
rs1217565283 1530 dbSNP
rs369417977 1534 dbSNP
rs767436597 1539 dbSNP
rs74096891 1556 dbSNP
rs544090163 1570 dbSNP
rs1452995165 1571 dbSNP
rs1236797972 1580 dbSNP
rs201010397 1581 dbSNP
rs372992116 1584 dbSNP
rs71714854 1584 dbSNP
rs3841329 1585 dbSNP
rs72508963 1586 dbSNP
rs1179583236 1592 dbSNP
rs960577922 1593 dbSNP
rs759097003 1597 dbSNP
rs776250780 1598 dbSNP
rs765771293 1600 dbSNP
rs1436667223 1604 dbSNP
rs1170349608 1608 dbSNP
rs1270258702 1618 dbSNP
rs983443031 1630 dbSNP
rs578129701 1638 dbSNP
rs923268550 1640 dbSNP
rs527390598 1642 dbSNP
rs1448757887 1644 dbSNP
rs372724107 1644 dbSNP
rs1329241114 1647 dbSNP
rs964678428 1649 dbSNP
rs1434538785 1650 dbSNP
rs1276752975 1651 dbSNP
rs907789356 1651 dbSNP
rs1218031096 1652 dbSNP
rs983667142 1662 dbSNP
rs1320576827 1665 dbSNP
rs955784362 1668 dbSNP
rs759691537 1669 dbSNP
rs1441404999 1676 dbSNP
rs3813603 1682 dbSNP
rs1196302414 1684 dbSNP
rs534863967 1684 dbSNP
rs1306232789 1687 dbSNP
rs1002581877 1715 dbSNP
rs996288035 1716 dbSNP
rs34184003 1719 dbSNP
rs190629346 1723 dbSNP
rs559076100 1726 dbSNP
rs1413057620 1730 dbSNP
rs1008907503 1732 dbSNP
rs1159568207 1744 dbSNP
rs1470069120 1745 dbSNP
rs1389740796 1757 dbSNP
rs1231711249 1758 dbSNP
rs552612360 1760 dbSNP
rs749649069 1761 dbSNP
rs1325791942 1767 dbSNP
rs1346316399 1789 dbSNP
rs186103771 1791 dbSNP
rs1256312940 1796 dbSNP
rs1031939762 1797 dbSNP
rs1318439765 1810 dbSNP
rs770227666 1826 dbSNP
rs1284673827 1829 dbSNP
rs1228756495 1830 dbSNP
rs1000742023 1831 dbSNP
rs942209595 1834 dbSNP
rs1223044865 1844 dbSNP
rs1211933917 1847 dbSNP
rs904718284 1869 dbSNP
rs907956560 1878 dbSNP
rs181183648 1880 dbSNP
rs933399660 1881 dbSNP
rs923241912 1884 dbSNP
rs112626699 1888 dbSNP
rs1356183565 1889 dbSNP
rs1471691878 1898 dbSNP
rs772142809 1902 dbSNP
rs1164742183 1912 dbSNP
rs964973564 1925 dbSNP
rs184282003 1926 dbSNP
rs990389345 1929 dbSNP
rs955834810 1933 dbSNP
rs1383329783 1937 dbSNP
rs747708467 1954 dbSNP
rs1400540187 1956 dbSNP
rs772000407 1961 dbSNP
rs939039260 1962 dbSNP
rs1247470938 1963 dbSNP
rs1002550846 1973 dbSNP
rs181630939 1975 dbSNP
rs1023032621 1977 dbSNP
rs1283329817 1981 dbSNP
rs1486568123 1989 dbSNP
rs551622572 1992 dbSNP
rs895377230 1993 dbSNP
rs1037995373 1997 dbSNP
rs1179664553 1999 dbSNP
rs1486639045 2005 dbSNP
rs1185250487 2014 dbSNP
rs930456994 2017 dbSNP
rs1385600255 2022 dbSNP
rs1006479891 2023 dbSNP
rs4399206 2028 dbSNP
rs974814089 2034 dbSNP
rs12043505 2036 dbSNP
rs1445102958 2047 dbSNP
rs1019040459 2059 dbSNP
rs987443844 2070 dbSNP
rs923408833 2084 dbSNP
rs1398272687 2085 dbSNP
rs1233837677 2090 dbSNP
rs1376607571 2091 dbSNP
rs1238352535 2096 dbSNP
rs144686811 2096 dbSNP
rs956077890 2099 dbSNP
rs1334143388 2101 dbSNP
rs1239170316 2108 dbSNP
rs1039439558 2117 dbSNP
rs1032325886 2129 dbSNP
rs1000475536 2133 dbSNP
rs1342841275 2137 dbSNP
rs774007768 2138 dbSNP
rs1205480171 2142 dbSNP
rs1226720282 2166 dbSNP
rs1364318971 2172 dbSNP
rs943423574 2175 dbSNP
rs746592481 2178 dbSNP
rs1023056188 2180 dbSNP
rs1252953482 2188 dbSNP
rs1419870410 2192 dbSNP
rs11161597 2199 dbSNP
rs1375993849 2200 dbSNP
rs894876426 2208 dbSNP
rs1386909566 2209 dbSNP
rs758367212 2212 dbSNP
rs989994633 2217 dbSNP
rs1328441154 2220 dbSNP
rs1462410840 2227 dbSNP
rs577460838 2233 dbSNP
rs1162068526 2237 dbSNP
rs563675373 2241 dbSNP
rs1333733121 2242 dbSNP
rs1375139898 2249 dbSNP
rs939009519 2253 dbSNP
rs1300079995 2254 dbSNP
rs1309925734 2257 dbSNP
rs934594091 2257 dbSNP
rs886131594 2258 dbSNP
rs543793910 2264 dbSNP
rs924422506 2265 dbSNP
rs1048107393 2270 dbSNP
rs1429803215 2271 dbSNP
rs930612990 2274 dbSNP
rs1265461510 2278 dbSNP
rs568190095 2292 dbSNP
rs1481461228 2309 dbSNP
rs370088681 2315 dbSNP
rs943200324 2322 dbSNP
rs1185583125 2325 dbSNP
rs911948673 2327 dbSNP
rs971539935 2331 dbSNP
rs1022745195 2340 dbSNP
rs189285424 2352 dbSNP
rs987581859 2358 dbSNP
rs572298519 2359 dbSNP
rs1031710690 2361 dbSNP
rs1364974193 2366 dbSNP
rs1406278491 2373 dbSNP
rs1283340621 2382 dbSNP
rs552697978 2389 dbSNP
rs968958942 2394 dbSNP
rs1467953738 2396 dbSNP
rs1307872567 2397 dbSNP
rs1220469939 2399 dbSNP
rs140978055 2412 dbSNP
rs1013010130 2413 dbSNP
rs1219399041 2428 dbSNP
rs573591650 2436 dbSNP
rs1477166371 2440 dbSNP
rs1034714956 2453 dbSNP
rs184549855 2459 dbSNP
rs886715960 2462 dbSNP
rs1026472528 2468 dbSNP
rs886099571 2468 dbSNP
rs1363358689 2473 dbSNP
rs1363381645 2484 dbSNP
rs1047356535 2491 dbSNP
rs997719604 2497 dbSNP
rs1442146975 2510 dbSNP
rs192500141 2519 dbSNP
rs1039081119 2520 dbSNP
rs943458309 2524 dbSNP
rs899056890 2534 dbSNP
rs1463016086 2541 dbSNP
rs764890220 2542 dbSNP
rs1246986076 2543 dbSNP
rs1354630338 2558 dbSNP
rs1169206227 2564 dbSNP
rs757086448 2570 dbSNP
rs150991136 2571 dbSNP
rs1313693315 2576 dbSNP
rs1243234976 2590 dbSNP
rs1483183202 2602 dbSNP
rs911750706 2602 dbSNP
rs41305858 2616 dbSNP
rs1194004307 2617 dbSNP
rs1446139519 2625 dbSNP
rs934796406 2629 dbSNP
rs1163839574 2634 dbSNP
rs924692332 2648 dbSNP
rs924556970 2652 dbSNP
rs1398482408 2655 dbSNP
rs981231203 2663 dbSNP
rs748564138 2672 dbSNP
rs1453598534 2678 dbSNP
rs949951338 2692 dbSNP
rs915731730 2700 dbSNP
rs991219605 2707 dbSNP
rs1384710088 2709 dbSNP
rs978762738 2716 dbSNP
rs969136707 2719 dbSNP
rs1308812926 2734 dbSNP
rs916151524 2735 dbSNP
rs553498436 2736 dbSNP
rs1251949185 2744 dbSNP
rs1434231944 2754 dbSNP
rs767845745 2766 dbSNP
rs1285006571 2767 dbSNP
rs1312185029 2785 dbSNP
rs991726446 2788 dbSNP
rs1245443357 2796 dbSNP
rs1204603974 2803 dbSNP
rs1462048292 2805 dbSNP
rs759675165 2810 dbSNP
rs960196417 2815 dbSNP
rs950937023 2816 dbSNP
rs3196 2820 dbSNP
rs143594639 2821 dbSNP
rs1035856290 2823 dbSNP
rs1413897179 2826 dbSNP
rs1174202781 2834 dbSNP
rs879064474 2839 dbSNP
rs774622409 2842 dbSNP
rs749441206 2849 dbSNP
rs901978232 2853 dbSNP
rs763516151 2854 dbSNP
rs1444629103 2859 dbSNP
rs533851327 2862 dbSNP
rs1367010263 2863 dbSNP
rs9388 2867 dbSNP
rs898859244 2873 dbSNP
rs1265575773 2885 dbSNP
rs1324836641 2886 dbSNP
rs1038950074 2898 dbSNP
rs1173931951 2904 dbSNP
rs184530362 2916 dbSNP
rs192648454 2923 dbSNP
rs1435789408 2927 dbSNP
rs1183518795 2933 dbSNP
rs116089840 2935 dbSNP
rs1433794467 2941 dbSNP
rs1375732818 2948 dbSNP
rs571275690 2952 dbSNP
Experimental Support 1 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
     
Conditions HEK293 , HUVEC , MCF7
Disease 23576.0;
Location of target site 3'UTR
Tools used in this research DIANA-microT , EIMMO , miRanda , miRBase Target Database , PicTar , TargetScan
Original Description (Extracted from the article) ... "miR-210 inhibited the reporter constructs containing an intact miR-210 binding site (pLUC-210-seed) ...

- Fasanaro P; Greco S; Lorenzi M; Pescatori et al., 2009, The Journal of biological chemistry.

Article - Fasanaro P; Greco S; Lorenzi M; Pescatori et al.
- The Journal of biological chemistry, 2009
miR-210 is a key player of cell response to hypoxia, modulating cell survival, VEGF-driven endothelial cell migration, and the ability of endothelial cells to form capillary-like structures. A crucial step in understanding microRNA (miRNA) function is the identification of their targets. However, only few miR-210 targets have been identified to date. Here, we describe an integrated strategy for large-scale identification of new miR-210 targets by combining transcriptomics and proteomics with bioinformatic approaches. To experimentally validate candidate targets, the RNA-induced silencing complex (RISC) loaded with miR-210 was purified by immunoprecipitation along with its mRNA targets. The complex was significantly enriched in mRNAs of 31 candidate targets, such as BDNF, GPD1L, ISCU, NCAM, and the non-coding RNA Xist. A subset of the newly identified targets was further confirmed by 3'-untranslated region (UTR) reporter assays, and hypoxia induced down-modulation of their expression was rescued blocking miR-210, providing support for the approach validity. In the case of 9 targets, such as PTPN1 and P4HB, miR-210 seed-pairing sequences localized in the coding sequence or in the 5'-UTR, in line with recent data extending miRNA targeting beyond the "classic" 3'-UTR recognition. Finally, Gene Ontology analysis of the targets highlights known miR-210 impact on cell cycle regulation and differentiation, and predicts a new role of this miRNA in RNA processing, DNA binding, development, membrane trafficking, and amino acid catabolism. Given the complexity of miRNA actions, we view such a multiprong approach as useful to adequately describe the multiple pathways regulated by miR-210 during physiopathological processes.
LinkOut: [PMID: 19826008]
MiRNA-Target Expression Profile
Dataset Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
MiRNA-Target Expression Profile (TCGA)
Tumor Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
HNSC -0.397 0 -0.351 0.01 42 Click to see details
LIHC 0.359 0.01 0.452 0 49 Click to see details
BLCA -0.503 0.02 -0.463 0.03 18 Click to see details
UCEC 0.416 0.04 0.453 0.03 19 Click to see details
STAD 0.282 0.06 0.311 0.04 32 Click to see details
PCPG -0.958 0.09 -1.000 0.5 3 Click to see details
PAAD -0.797 0.1 -0.800 0.1 4 Click to see details
CHOL 0.457 0.11 0.317 0.2 9 Click to see details
THCA -0.16 0.11 -0.112 0.2 59 Click to see details
LUAD -0.283 0.19 -0.399 0.1 12 Click to see details
PRAD 0.088 0.27 0.138 0.17 50 Click to see details
KIRC 0.072 0.28 0.028 0.41 68 Click to see details
BRCA 0.056 0.31 0.108 0.16 84 Click to see details
KIRP -0.092 0.31 -0.080 0.33 32 Click to see details
COAD 0.195 0.32 0.190 0.33 8 Click to see details
CESC 0.379 0.38 0.500 0.33 3 Click to see details
LUSC 0.04 0.41 0.032 0.42 38 Click to see details
ESCA -0.07 0.42 -0.027 0.47 11 Click to see details
KICH 0.037 0.43 -0.043 0.42 25 Click to see details
KICH 0.037 0.43 -0.043 0.42 25 Click to see details
KICH 0.037 0.43 -0.043 0.42 25 Click to see details
126 hsa-miR-210-3p Target Genes:
Functional analysis:
ID Target Description Validation methods
Strong evidence Less strong evidence
MIRT000149 HOXA9 homeobox A9 4 1
MIRT000150 TP53I11 tumor protein p53 inducible protein 11 2 1
MIRT000151 PIM1 Pim-1 proto-oncogene, serine/threonine kinase 2 1
MIRT000152 HOXA1 homeobox A1 2 1
MIRT000153 FGFRL1 fibroblast growth factor receptor like 1 6 3
MIRT000156 RAD52 RAD52 homolog, DNA repair protein 5 3
MIRT001930 NPTX1 neuronal pentraxin 1 3 2
MIRT002024 EFNA3 ephrin A3 8 8
MIRT003153 BDNF brain derived neurotrophic factor 5 1
MIRT003154 PTPN1 protein tyrosine phosphatase, non-receptor type 1 5 1
MIRT003155 P4HB prolyl 4-hydroxylase subunit beta 6 2
MIRT003156 UBQLN1 ubiquilin 1 3 1
MIRT003157 SERTAD2 SERTA domain containing 2 3 1
MIRT003158 SEH1L SEH1 like nucleoporin 3 1
MIRT003159 NCAM1 neural cell adhesion molecule 1 4 1
MIRT003160 MID1IP1 MID1 interacting protein 1 3 1
MIRT003161 MDGA1 MAM domain containing glycosylphosphatidylinositol anchor 1 3 1
MIRT003162 KIAA1161 myogenesis regulating glycosidase (putative) 3 1
MIRT003163 ISCU iron-sulfur cluster assembly enzyme 6 7
MIRT003164 HOXA3 homeobox A3 3 1
MIRT003165 GPD1L glycerol-3-phosphate dehydrogenase 1 like 7 2
MIRT003166 DENND6A DENN domain containing 6A 3 1
MIRT003167 CPEB2 cytoplasmic polyadenylation element binding protein 2 5 1
MIRT003168 CDK10 cyclin dependent kinase 10 3 1
MIRT003169 ABCB9 ATP binding cassette subfamily B member 9 3 1
MIRT003170 CBX1 chromobox 1 3 1
MIRT003171 XIST X inactive specific transcript (non-protein coding) 4 1
MIRT003172 TNPO1 transportin 1 3 1
MIRT003173 SMCHD1 structural maintenance of chromosomes flexible hinge domain containing 1 3 1
MIRT003174 PTAR1 protein prenyltransferase alpha subunit repeat containing 1 3 1
MIRT003175 NIPBL NIPBL, cohesin loading factor 3 1
MIRT003176 MIB1 mindbomb E3 ubiquitin protein ligase 1 3 1
MIRT003177 HECTD1 HECT domain E3 ubiquitin protein ligase 1 3 1
MIRT003178 ELK3 ELK3, ETS transcription factor 3 1
MIRT003179 DDAH1 dimethylarginine dimethylaminohydrolase 1 4 1
MIRT003180 CLASP2 cytoplasmic linker associated protein 2 3 1
MIRT003181 CHD9 chromodomain helicase DNA binding protein 9 3 1
MIRT003182 ATP11C ATPase phospholipid transporting 11C 3 1
MIRT003183 APC APC, WNT signaling pathway regulator 3 1
MIRT003184 E2F3 E2F transcription factor 3 7 5
MIRT003185 ACVR1B activin A receptor type 1B 2 1
MIRT003916 MRE11A MRE11 homolog, double strand break repair nuclease 2 1
MIRT003917 XPA XPA, DNA damage recognition and repair factor 2 1
MIRT004672 MNT MAX network transcriptional repressor 4 2
MIRT006326 AIFM3 apoptosis inducing factor, mitochondria associated 3 3 2
MIRT006519 CASP8AP2 caspase 8 associated protein 2 4 1
MIRT006663 VMP1 vacuole membrane protein 1 3 2
MIRT006830 TFRC transferrin receptor 3 2
MIRT047002 PFDN2 prefoldin subunit 2 1 1
MIRT047003 U2AF2 U2 small nuclear RNA auxiliary factor 2 1 1
MIRT047004 UBA1 ubiquitin like modifier activating enzyme 1 1 1
MIRT047005 ESPL1 extra spindle pole bodies like 1, separase 1 1
MIRT047006 ACTR1A ARP1 actin related protein 1 homolog A 1 1
MIRT047007 SCN1B sodium voltage-gated channel beta subunit 1 1 1
MIRT047008 RCC2 regulator of chromosome condensation 2 1 1
MIRT053179 HSD17B1 hydroxysteroid 17-beta dehydrogenase 1 2 1
MIRT054098 NDUFA4 NDUFA4, mitochondrial complex associated 4 2
MIRT054099 SDHD succinate dehydrogenase complex subunit D 6 4
MIRT054141 STMN1 stathmin 1 3 1
MIRT054142 DIMT1L DIM1 dimethyladenosine transferase 1 homolog 4 2
MIRT054186 ROD1 polypyrimidine tract binding protein 3 3 1
MIRT054203 ALDH5A1 aldehyde dehydrogenase 5 family member A1 4 1
MIRT054204 FOXN3 forkhead box N3 5 2
MIRT054205 MCM3 minichromosome maintenance complex component 3 4 1
MIRT054206 IGFBP3 insulin like growth factor binding protein 3 6 2
MIRT054207 COL4A2 collagen type IV alpha 2 chain 6 2
MIRT054208 INPP5A inositol polyphosphate-5-phosphatase A 4 1
MIRT054209 EHD2 EH domain containing 2 4 1
MIRT054210 SH3BGRL SH3 domain binding glutamate rich protein like 5 2
MIRT054248 PTPN2 protein tyrosine phosphatase, non-receptor type 2 3 1
MIRT054321 LDHA lactate dehydrogenase A 2 1
MIRT054324 LDHB lactate dehydrogenase B 2 1
MIRT054349 HIF1A hypoxia inducible factor 1 alpha subunit 5 2
MIRT054714 FOXP3 forkhead box P3 3 1
MIRT054794 HIF3A hypoxia inducible factor 3 alpha subunit 3 1
MIRT115688 MGRN1 mahogunin ring finger 1 2 3
MIRT170674 INSIG1 insulin induced gene 1 1 1
MIRT437785 BNIP3 BCL2 interacting protein 3 5 2
MIRT438739 KCMF1 potassium channel modulatory factor 1 1 1
MIRT439407 TNPO3 transportin 3 1 1
MIRT439629 SIPA1L3 signal induced proliferation associated 1 like 3 1 1
MIRT439632 SIN3A SIN3 transcription regulator family member A 1 1
MIRT439740 RPL22 ribosomal protein L22 1 1
MIRT439886 PSAP prosaposin 1 1
MIRT439918 PPP1R2 protein phosphatase 1 regulatory inhibitor subunit 2 1 1
MIRT439928 POU2AF1 POU class 2 associating factor 1 1 1
MIRT440033 ICMT isoprenylcysteine carboxyl methyltransferase 2 3
MIRT440255 MEF2D myocyte enhancer factor 2D 1 1
MIRT440491 HMGCS1 3-hydroxy-3-methylglutaryl-CoA synthase 1 2 3
MIRT440570 GIT2 GIT ArfGAP 2 1 1
MIRT440647 FCHSD2 FCH and double SH3 domains 2 1 1
MIRT440830 DEAF1 DEAF1, transcription factor 1 1
MIRT440866 CSNK1E casein kinase 1 epsilon 1 1
MIRT472232 NFIC nuclear factor I C 2 2
MIRT473190 MITF melanogenesis associated transcription factor 2 2
MIRT477856 DYRK2 dual specificity tyrosine phosphorylation regulated kinase 2 2 2
MIRT497528 ZNF607 zinc finger protein 607 2 2
MIRT509770 SERTM1 serine rich and transmembrane domain containing 1 2 6
MIRT524407 CNTNAP5 contactin associated protein like 5 2 4
MIRT535209 PKIA cAMP-dependent protein kinase inhibitor alpha 2 4
MIRT554511 RUNX1T1 RUNX1 translocation partner 1 2 4
MIRT558069 ESCO2 establishment of sister chromatid cohesion N-acetyltransferase 2 2 2
MIRT572273 KCNJ6 potassium voltage-gated channel subfamily J member 6 2 2
MIRT574255 DOCK7 dedicator of cytokinesis 7 2 4
MIRT575621 Foxn3 forkhead box N3 2 2
MIRT575742 Zfp618 zinc finger protein 618 1 1
MIRT609050 VAMP4 vesicle associated membrane protein 4 2 2
MIRT611143 TNRC6B trinucleotide repeat containing 6B 2 4
MIRT699226 SLCO3A1 solute carrier organic anion transporter family member 3A1 2 2
MIRT703060 GTDC1 glycosyltransferase like domain containing 1 2 2
MIRT716005 ASB11 ankyrin repeat and SOCS box containing 11 2 2
MIRT731682 BTK Bruton tyrosine kinase 3 1
MIRT733090 DLEU2L deleted in lymphocytic leukemia 2-like 3 0
MIRT733091 BRCA2 BRCA2, DNA repair associated 3 0
MIRT733156 ITGA5 integrin subunit alpha 5 1 0
MIRT733501 GATA1 GATA binding protein 1 3 0
MIRT733503 SMAD2 SMAD family member 2 3 0
MIRT733525 MIR210HG MIR210 host gene 2 0
MIRT733615 TGFBI transforming growth factor beta induced 2 0
MIRT734175 KRAS KRAS proto-oncogene, GTPase 2 0
MIRT734293 PTEN phosphatase and tensin homolog 1 0
MIRT734568 STAT6 signal transducer and activator of transcription 6 1 0
MIRT734966 ADAMTS6 ADAM metallopeptidase with thrombospondin type 1 motif 6 1 0
MIRT736294 ID2 inhibitor of DNA binding 2, HLH protein 1 0
MIRT737104 FABP4 fatty acid binding protein 4, adipocyte 3 0
MIRT756028 NTN4 netrin 4 3 1
miRNA-Drug Associations
miRNA Small Melocule FDA CID Detection Method Condition PMID Year Expression Pattern of miRNA
miR-210 Vincristine approved 5978 Quantitative real-time PCR Hep-2 cells 23780424 2013 up-regualted
miR-210 Lenalidomide approved 216326 Quantitative real-time PCR peripheral blood CD14+ monocytes 25287904 2014 down-regulated
miR-210 Arsenic trioxide approved 14888 Microarray lymphoblast cell line TK-6 17108120 2006 down-regulated
miR-210 5-Fluorouracil approved 3385 Quantitative real-time PCR colon cancer cells 17702597 2007 down-regulated
miR-210 Arsenic trioxide approved 14888 Microarray HepG-2 human hepatocellular carcinoma cell line 21175813 2011 up-regulated
miR-210 Arsenic trioxide approved 14888 Quantitative real-time PCR HepG-2 human hepatocellular carcinoma cell line 21175813 2011 up-regulated
miR-210 Arsenic trioxide approved 14888 Quantitative real-time PCR HepG-2 human hepatocellular carcinoma cell line 21175813 2011 up-regulated
miR-210 Ginsenoside Rh2 NULL 119307 Microarray human glioma cells U251 21372826 2011 down-regulated
miR-210 Aidi injection NULL NULL Microarray human breast cancer cells 21563499 2011 down-regulated
miR-210 5-aza-2'-deoxycytidine (5-Aza-CdR) approved 451668 Microarray breast cancer HB2 22076154 2011 down-regulated
miR-210 5-aza-2'-deoxycytidine (5-Aza-CdR) approved 451668 Microarray breast cancer MDA-MB231 22076154 2011 down-regulated
miR-210 5-aza-2'-deoxycytidine (5-Aza-CdR) approved 451668 Microarray breast cancer SKBR3 22076154 2011 down-regulated
miR-210 Trastuzumab approved NULL Microarray HER2-positive breast cancer 22384020 2012 down-regulated
miR-210 Trastuzumab approved NULL Quantitative real-time PCR HER2-positive breast cancer 22384020 2012 down-regulated
miR-210 Trastuzumab approved NULL Microarray BT474 cells 22384020 2012 down-regulated
miR-210 Curcumin NULL 969516 Quantitative real-time PCR Y79 RB cells. 22510010 2012 down-regulated
miR-210 Bicalutamide approved 2375 Microarray prostate 22674191 2012 down-regulated
miR-210 Goserelin approved 47725 Microarray prostate 22674191 2012 down-regulated
miR-210 Olea europaea leaf extract NULL NULL Quantitative real-time PCR glioblastoma cells. 22722712 2012 up-regulated
miR-210 Temozolomide approved 5394 Quantitative real-time PCR glioblastoma cells. 22722712 2012 up-regulated
miR-210 Nicotine approved 89594 Microarray Rat adrenal pheochromocytoma PC12 cell 18845019 2009 down-regulated
miR-210 Comfrey NULL 6440495 Microarray rat liver 21370286 2011 up-regulated
miRNA-Drug Resistance Associations
miRNA Drug Name CID NSC FDA Effect/Pattern Detection Method Level Phenotype Condition
hsa-mir-210 Cisplatin 5460033 NSC119875 approved resistant High Gastric Cancer cell line (BGC823)
hsa-mir-210 Ceritinib 57379345 NSC776422 approved resistant High Non-Small Cell Lung Cancer cell line (H3122, H2228)
hsa-mir-210 Dabrafenib 44462760 NSC764134 approved resistant cell line (A375)
hsa-mir-210 Paclitaxel 36314 NSC125973 approved resistant cell line (W1)
hsa-mir-210 Androstenedione 6128 NSC9563 sensitive cell line (MCF-7)
hsa-mir-210 Androstenedione+Letrozole sensitive cell line (MCF-7)
hsa-mir-210 Tamoxifen 2733525 NSC180973 approved resistant tissue (ER-positive breast cancer)
hsa-mir-210 Fluorouracil 3385 NSC19893 approved sensitive cell line (OE19)
hsa-mir-210 Ceritinib 57379345 NSC776422 approved resistant cell line (H3122)
hsa-mir-210 Cisplatin 5460033 NSC119875 approved resistant cell line (BGC-823)
hsa-miR-210-3p (E)-1-[3,5-bis[(dimethylamino)methyl]-4-hydroxyphenyl]-3-phenylprop-2-en-1-one 6374691 NSC677784 resistant
hsa-miR-210-3p (e)-3-chloro-3-(4-methoxyphenyl)-2-(4-nitrophenyl)prop-2-enal 5387396 NSC623175 resistant
hsa-miR-210-3p [(E)-(1-chloro-2-methylpropylidene)amino] N-anilinocarbamate 5494354 NSC682841 resistant
hsa-miR-210-3p [(E)-1-chloropropylideneamino] N-[2-(trifluoromethoxy)phenyl]carbamate 5466266 NSC682836 resistant
hsa-miR-210-3p [2-[(e)-(carbamothioylhydrazono)methyl]-6-methoxy-phenoxy]-hydroxy-copper; 2-(2-pyridyl)pyridine 135484845 NSC638302 resistant
hsa-miR-210-3p 1-(4-ethoxyphenyl)-3-(2-methyl-5-propan-2-ylphenyl)urea 240168 NSC46213 sensitive
hsa-miR-210-3p 1-(4-nitrophenyl)-3-(2-pyridyl)thiourea 3005383 NSC695329 sensitive
hsa-miR-210-3p 1-(naphthalen-1-ylmethyl)-4-[1-(naphthalen-1-ylmethyl)piperidin-4-yl]piperidine 364095 NSC669995 resistant
hsa-miR-210-3p 1-[2-(4-nitrophenyl)-2-oxoethyl]-4-pentylpyridin-1-ium bromide 24181037 NSC4290 resistant
hsa-miR-210-3p 11-(3-methoxyphenyl)-2,12,15-triazapentacyclo[11.7.1.03,8.09,21.014,19]henicosa-1,3,5,7,9,11,13(21),14(19),15,17-decaen-20-one 54608964 NSC697747 resistant
hsa-miR-210-3p 17-acetyl-9,14-dihydroxy-16-methyl-15-(4-methylphenyl)-15-azatetracyclo[8.7.0.01,14.03,8]heptadeca-3,5,7,9,12,16-hexaene-2,11-dione 405612 NSC722982 resistant
hsa-miR-210-3p 1h-benz[g]indol-5-ol, 2-phenyl 371327 NSC645431 resistant
hsa-miR-210-3p 2-[[4-anilino-5-[8-[4-anilino-5-[(1-hydroxynaphthalen-2-yl)oxymethyl]-1,2,4-triazol-3-yl]octyl]-1,2,4-triazol-3-yl]methoxy]naphthalen-1-ol 394049 NSC697167 resistant
hsa-miR-210-3p 2-[9-[(7-oxocyclohepta-1,3,5-trien-1-yl)amino]nonylamino]cyclohepta-2,4,6-trien-1-one 358331 NSC618296 resistant
hsa-miR-210-3p 2-amino-5,8-dihydroxy-1,4-naphthoquinone 377209 NSC658441 resistant
hsa-miR-210-3p 2-bromo-4-(5-fluoro-1,3-benzothiazol-2-yl)aniline 399248 NSC709925 sensitive
hsa-miR-210-3p 2-hydroxy-5-({(e)-[(10-hydroxyacridin-9(10h)-ylidene)methyl]diazenyl}sulfonyl)benzoic acid 363212 NSC627890 resistant
hsa-miR-210-3p 3'-chloro-3-nitro-o-salicylotoluidide 332278 NSC328477 resistant
hsa-miR-210-3p 3-((4-(methylthio)phenoxy)methyl)-2-oxiranol 366923 NSC636087 resistant
hsa-miR-210-3p 4-(2-phenylethylamino)naphthalene-1,2-dione 367789 NSC637731 resistant
hsa-miR-210-3p 4-[(E)-2-piperidin-1-ylethenyl]benzo[g]quinoline-5,10-dione 5781544 NSC642968 resistant
hsa-miR-210-3p 4-[(r)-[(2s,5r)-2,5-dimethyl-4-prop-2-enylpiperazin-1-yl]-(3-methoxyphenyl)methyl]-n-pentan-3-ylbenzamide;hydrochloride 5471112 NSC708822 resistant
hsa-miR-210-3p 4-[2-(methylamino)-1-methylsulfanylethyl]benzene-1,2-diol 412349 NSC39215 resistant
hsa-miR-210-3p 4-[4-(4-sulfinobutyldisulfanyl)butyldisulfanyl]butane-1-sulfinic acid 361262 NSC624205 resistant
hsa-miR-210-3p 4-acetamido-n-[(e)-(2,4-dichlorophenyl)methylideneamino]-2-methoxybenzamide 9572428 NSC716142 sensitive
hsa-miR-210-3p 4-aminodithiolane-4-carboxylic acid 269217 NSC109825 resistant
hsa-miR-210-3p 4-hydroxy-3-[1-(1-hydroxy-3,4-dioxonaphthalen-2-yl)-3-phenylpropyl]naphthalene-1,2-dione 272651 NSC117274 resistant
hsa-miR-210-3p 4,4-dimethylspiro[1,3,2-oxazaphospholidin-2-ium-2,2'-3h-1,3,2-benzoxazaphosphol-2-ium]-5-one 6330525 NSC351866 resistant
hsa-miR-210-3p 4b-hydroxy-10,10-dimethoxy-9ah-indeno[1,2-a]inden-9-one 363252 NSC628000 resistant
hsa-miR-210-3p 4h,7h-furo[2',3',4':4,5]naphth[2,1-e][1,3]oxazin-4-one, 8-(4-chlorophenyl)-8,9-dihydro- 373969 NSC651001 resistant
hsa-miR-210-3p 5,6,7-trimethoxy-N-(4H-pyrazolo[1,5-a]indol-2-yl)-1H-indole-2-carboxamide 404173 NSC720326 resistant
hsa-miR-210-3p 6-(3-chloropropyl)-3-nitroindeno[1,2-c]isoquinoline-5,11-dione 17755848 NSC731154 resistant
hsa-miR-210-3p 6-benzyloxyhexanal 389877 NSC686505 resistant
hsa-miR-210-3p 7-[(E)-2-(1,6-dimethylquinolin-1-ium-2-yl)ethenyl]-5-methylquinolin-8-ol 135483953 NSC86371 resistant
hsa-miR-210-3p 7-[(naphthalen-1-ylamino)(phenyl)methyl]quinolin-8-ol 256754 NSC84092 resistant
hsa-miR-210-3p 7-chloro-6-n-(2-fluoroethylamino)-5,8-quinolinedione 379079 NSC663286 resistant
hsa-miR-210-3p 7-o,8-o-isopropylidene iriomoteolide 3a 24808220 NSC753164 resistant
hsa-miR-210-3p 9h-quino[4,3,2-de][1,10]phenanthrolin-9-one, 2-phenyl- 4567749 NSC686553 resistant
hsa-miR-210-3p Acetyltrophanthidin 261075 NSC92954 resistant
hsa-miR-210-3p Adenosine, 2-bromo-2'-deoxy- 334838 NSC341936 resistant
hsa-miR-210-3p Asimicinone 393461 NSC695394 resistant
hsa-miR-210-3p Benzo[b]naphtho[2,3-d]furan-6,11-dione, 4-chloro-3-hydroxy 371025 NSC644902 resistant
hsa-miR-210-3p Benzo[g]pteridine-2,4(3h,10h)-dione, 10-(2,4-dimethylphenyl)-3-methyl- 363228 NSC627974 resistant
hsa-miR-210-3p Benzo[g]pteridine-2,4(3h,10h)-dione, 10-(4-chlorophenyl)-3,7,8-trimethyl- 363246 NSC627992 resistant
hsa-miR-210-3p Benzo[g]pteridine-2,4(3h,10h)-dione, 3-methyl-10-[3-(methylthio)phenyl]- 363242 NSC627988 resistant
hsa-miR-210-3p Benzo[g]quinoxaline-5,10-dione, 5,10-dihydro-2,3-dimethyl- 353644 NSC602617 resistant
hsa-miR-210-3p Celcot rm 67277 NSC37168 resistant
hsa-miR-210-3p Cytarabine 6253 NSC287459 approved resistant
hsa-miR-210-3p Destruxin a 122810 NSC361126 resistant
hsa-miR-210-3p Di-p-tolyliodinium bromide 54601177 NSC8985 resistant
hsa-miR-210-3p Diethoxybis(1,4-naphthochinone-2-olato)titanium(iv) 368297 NSC638842 resistant
hsa-miR-210-3p Dihydrorotenone 243725 NSC53866 resistant
hsa-miR-210-3p Diisopropoxybis(1,4-naphthochinone-2-olato)titanium(iv) 368058 NSC638383 resistant
hsa-miR-210-3p Discorhabdin i 135409047 NSC656206 resistant
hsa-miR-210-3p Dpbq 364074 NSC629713 resistant
hsa-miR-210-3p Ethyl 6-chloro-4-phenyl-2-(piperazin-1-ylmethyl)quinoline-3-carboxylate 369623 NSC641536 resistant
hsa-miR-210-3p Ethyl 6-hydroxy-4-(4-methoxyphenyl)-6-methyl-3-oxo-2-phenyl-1,4,5,7-tetrahydroindazole-5-carboxylate 392845 NSC693857 resistant
hsa-miR-210-3p Gnmlngdfmleynr-uhfffaoysa-n 402862 NSC717147 sensitive
hsa-miR-210-3p Gw612286x 9822610 NSC756278 sensitive
hsa-miR-210-3p Gw811761x 6539382 NSC756375 sensitive
hsa-miR-210-3p Herbimycin 6436247 NSC305978 resistant
hsa-miR-210-3p Hypothemycin 5458809 NSC354462 resistant
hsa-miR-210-3p Indole-2,3-dione, 5-methyl-, 3-[(o-nitrophenyl)hydrazone] 3632950 NSC117915 sensitive
hsa-miR-210-3p J3.572.907k 396709 NSC703318 resistant
hsa-miR-210-3p Methyl 10-acetyl-3-(4-methylphenyl)sulfonyl-9-(2-methylprop-1-enyl)-3,10-diazatricyclo[6.4.1.04,13]trideca-1,4,6,8(13),11-pentaene-11-carboxylate NSC621968 resistant
hsa-miR-210-3p Methyl 8-[(4-chlorophenyl)carbamoyl]naphthalene-1-carboxylate 364289 NSC630307 resistant
hsa-miR-210-3p N-(2-morpholin-4-ylethyl)-5-nitroquinolin-4-amine;hydrochloride 372042 NSC646859 resistant
hsa-miR-210-3p N-(3-chloro-1,4-dioxonaphthalen-2-yl)-4-naphthalen-2-yl-2,4-dioxo-3-(3-oxo-1H-2-benzofuran-1-yl)butanamide 369463 NSC641233 resistant
hsa-miR-210-3p N-(3,5-dicyano-2-(4-methylphenyl)-6-oxo-4-phenyl-1(6h)-pyridinyl)-4-methylbenzenesulfonamide 390286 NSC687578 resistant
hsa-miR-210-3p N-[(1E)-1-(1-hydroxypyridin-2-ylidene)ethyl]iminoazepane-1-carbothioamide 5369124 NSC351075 resistant
hsa-miR-210-3p N-[1,1,1,3,3,3-hexafluoro-2-(4-fluoroanilino)propan-2-yl]butanamide 389152 NSC684836 resistant
hsa-miR-210-3p Naphtho[2,3-d]-1,3-dioxepin-6,11-dione, 4-methyl- NSC626868 resistant
hsa-miR-210-3p Naphtho[2,3-d]oxazole-4,9-dione, 2-(1,1-dimethylethyl)- 370622 NSC643915 resistant
hsa-miR-210-3p Niosh/br9826000 359483 NSC620462 resistant
hsa-miR-210-3p NSC619321 NSC619321 sensitive
hsa-miR-210-3p NSC621321 NSC621321 resistant
hsa-miR-210-3p NSC631451 NSC631451 resistant
hsa-miR-210-3p NSC634766 NSC634766 resistant
hsa-miR-210-3p NSC635414 NSC635414 resistant
hsa-miR-210-3p Pentyl 6-(chloromethyl)-2-oxo-2h-chromene-3-carboxylate 402498 NSC716524 resistant
hsa-miR-210-3p Pmp (van) 72508 NSC1906 resistant
hsa-miR-210-3p Scillirosidin, glycoside 222160 NSC7534 resistant
hsa-miR-210-3p Sesbanimide 163490 NSC355461 resistant
hsa-miR-210-3p Snc 80 123924 NSC707484 resistant
hsa-miR-210-3p Streptovaricin b 135443622 NSC156215 resistant
hsa-miR-210-3p Tetratert-butyl 8,11-dimethoxytricyclo[4.3.3.01,6]dodeca-7,10-diene-7,9,10,12-tetracarboxylate 362411 NSC626176 resistant
hsa-miR-210-3p Tolonium chloride 7083 NSC36758 resistant
hsa-miR-210-3p Z48861686 4784054 NSC745813 resistant
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved resistant High Breast Cancer cell line (MCF-7)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved sensitive High Breast Cancer cell line (MCF-7)
hsa-miR-210-3p Temozolomide 5394 NSC362856 approved resistant High Glioblastoma cell line (U251MG, U251R, U87MG, M059K, M059J)
hsa-miR-210-3p Imatinib 5291 NSC743414 approved resistant High Myelogenous Leukemia cell line (MYL)
hsa-miR-210-3p Methotrexate 126941 NSC740 approved resistant High Colon Cancer cell line (HT-29)
hsa-miR-210-3p Methotrexate 126941 NSC740 approved resistant High Colon Cancer cell line (HT-29)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved resistant High Ehrlich Ascites Tumor cell line (EHR2,P6, P12, P36, P72, EHR2/1.3)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved resistant High Ehrlich Ascites Tumor cell line (EHR2,P6, P12, P36, P72, EHR2/1.3)
hsa-miR-210-3p Trastuzumab resistant Low Breast Cancer tissue and cell line (BT-474, BTR65)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive High Gastric Cancer cell line (SGC7901)
hsa-miR-210-3p Vincristine 5978 approved sensitive High Gastric Cancer cell line (SGC7901)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved sensitive High Gastric Cancer cell line (SGC7901)
hsa-miR-210-3p Fluorouracil 3385 NSC19893 approved sensitive High Gastric Cancer cell line (SGC7901)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved resistant Low Cervical Cancer tissue and cell line (SiHa, Cask)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved resistant High Laryngeal Cancer cell line (Hep2)
hsa-miR-210-3p Fluorouracil + Oxaliplatin resistant High Colorectal Cancer tissue
hsa-miR-210-3p Docetaxel 148124 NSC628503 approved resistant High Prostate Cancer cell line (DU-145)
hsa-miR-210-3p Asparaginate 5460875 sensitive Low Pediatric Acute Lymphoblastic Leukemia Reh cells
hsa-miR-210-3p Dexamethasone 5743 NSC34521 approved sensitive Low Pediatric Acute Lymphoblastic Leukemia Reh cells
hsa-miR-210-3p Daunorubicin 30323 NSC82151 approved sensitive Low Pediatric Acute Lymphoblastic Leukemia Reh cells
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved resistant High Pancreatic Cancer cell line (PANC-1)
hsa-miR-210-3p Fluorouracil 3385 NSC19893 approved resistant High Pancreatic Cancer cell line (PANC-1)
hsa-miR-210-3p Fluorouracil 3385 NSC19893 approved sensitive High Esophageal Adenocarcinoma cell line (OE19)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved resistant High Hepatocellular Carcinoma tissue and cell line (HepG2)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved sensitive High Pancreatic Cancer cell line (SW1990)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved resistant High Pancreatic Cancer cell line (SW1990)
hsa-miR-210-3p Taxane 9548828 sensitive High Prostate Cancer cell line (PC-3, PR20)
hsa-miR-210-3p Taxane 9548828 sensitive High Prostate Cancer cell line (PC-3, PR70)
hsa-miR-210-3p Dexamethasone 5743 NSC34521 approved sensitive High Myeloma cell line (MM1R, MM1S)
hsa-miR-210-3p Platinum 23939 sensitive High Ovarian Cancer tissue
hsa-miR-210-3p Daunorubicin 30323 NSC82151 approved sensitive High Acute Myeloid Leukemia cell line (U-937, KG-1)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved resistant Low Pancreatic Ductal Adenocarcinoma cell line (MIA-PaCa-2)
hsa-miR-210-3p Trametinib 11707110 NSC758246 approved sensitive Low Melanoma cell line (MML-1)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved resistant High Ovarian Cancer cell line (SKOV3)
hsa-miR-210-3p Tamoxifen 2733525 NSC180973 approved resistant Low Breast Cancer cell line (TAMR4, TAMR8)
hsa-miR-210-3p Aromatase Inhibitor sensitive Low Breast Cancer cell line (MCF-7)
hsa-miR-210-3p Epirubicin 41867 NSC256942 approved resistant High Breast Cancer cell line (MDA-MB-231)
hsa-miR-210-3p Docetaxel 148124 NSC628503 approved resistant High Breast Cancer cell line (MDA-MB-231)
hsa-miR-210-3p Vinorelbine 44424639 approved resistant High Breast Cancer cell line (MDA-MB-231)
hsa-miR-210-3p 1'-Acetoxychavicol acetate 119104 NSC711510 resistant Low Cervical Cancer cell line (Ca Ski, SiHa)
hsa-miR-210-3p Dabrafenib 44462760 NSC764134 approved sensitive High Melanoma cell line (A375, IGR37, 501Mel)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved sensitive High Melanoma cell line (A375, IGR37, 501Mel)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive High Non-Small Cell Lung Cancer cell line (A549)
hsa-miR-210-3p Imatinib 5291 NSC743414 approved sensitive High Chronic Myelogenous Leukemia cell line (K562)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved sensitive Low Renal Cell Cancer cell line (Caki-2)
hsa-miR-210-3p Vinblastine 442111 NSC90636 approved sensitive Low Renal Cell Cancer cell line (Caki-2)
hsa-miR-210-3p Fulvestrant 17756771 NSC719276 approved resistant High Breast Cancer cell line (MCF-7)
hsa-miR-210-3p Ceritinib 57379345 NSC776422 approved resistant High Non-Small Cell Lung Cancer cell line (H3122, H2228)
hsa-miR-210-3p Methotrexate 126941 NSC740 approved resistant High Colorectal Cancer cell line (LS174T)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved resistant Low Cholangiocarcinoma cell line (KKU-213, KKU-055, KKU-100)
hsa-miR-210-3p Docetaxel 148124 NSC628503 approved resistant Low Breast Cancer tissue
hsa-miR-210-3p Palbociclib 5330286 NSC758247 approved sensitive High Breast Cancer cell line (T47D)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive High Ovarian Cancer cell line (SKOV3)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive Low Ovarian Cancer cell line (SKOV3)
hsa-miR-210-3p Cetuximab + Folfox(Fluorouracil + Leucovorin + Oxaliplatin) sensitive High Metastatic Colorectal Cancer tissue
hsa-miR-210-3p Fluorouracil 3385 NSC19893 approved sensitive Low Colorectal Cancer cell line (HT-29)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved resistant Low Pancreatic Cancer cell line (BXPC-3)
hsa-miR-210-3p Methotrexate 126941 NSC740 approved resistant High Colorectal Adenocarcinoma cell line (HT-29)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved resistant Low Pancreatic Cancer cell line (PANC-1)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved resistant Low Oral Cancer cell line (SAS, HSC-3, HSC-4)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive High Endometrial Serous Carcinoma cell line (USPC1)
hsa-miR-210-3p Imatinib 5291 NSC743414 approved sensitive Low Chronic Myelogenous Leukemia tissue
hsa-miR-210-3p Dabrafenib 44462760 NSC764134 approved resistant High Melanoma cell line (A375)
hsa-miR-210-3p Sunitinib 5329102 NSC750690 approved resistant Low Renal Cell Cancer tissue
hsa-miR-210-3p Temozolomide 5394 NSC362856 approved resistant Low Glioma cell line (U87)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive High Hypopharyngeal Cancer cell line (FaDu)
hsa-miR-210-3p Platinum 23939 resistant High High-Grade Serous Ovarian Cancer tissue
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive Low Breast Cancer cell line (MCF-7)
hsa-miR-210-3p Sorafenib 216239 NSC747971 approved resistant High Hepatocellular Carcinoma cell line (PLC/PRF5-R1, PLC/PRF5-R2, PLC/PRF5)
hsa-miR-210-3p Gefitinib 123631 NSC715055 approved sensitive cell line (HCC827)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved sensitive cell line (A375)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive cell line (CAL-27) (total RNA)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive cell line (CAL-27) (mitochondrial RNA)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved sensitive cell line (451Lu)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved resistant cell line
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive cell line (A549)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved resistant cell line (SKVO3ip1)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive cell line (HeyA8)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved sensitive cell line (LM17)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved resistant cell line (LM16)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved sensitive cell line (LM11)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved resistant cell line (LM43)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved resistant cell line (LM47)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved sensitive cell line (HS578T)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved resistant cell line (BAS)
hsa-miR-210-3p Tamoxifen+Fulvestrant sensitive cell line (LCC9)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved resistant cell line (CIS)
hsa-miR-210-3p Exemestane 60198 NSC713563 approved resistant cell line (MCF-7)
hsa-miR-210-3p Testosterone 6013 NSC9700 approved resistant cell line (MCF-7)
hsa-miR-210-3p Testosterone+Exemestane resistant cell line (MCF-7)
hsa-miR-210-3p Testosterone+Letrozole resistant cell line (MCF-7)
hsa-miR-210-3p Testosterone+Anastrozole resistant cell line (MCF-7)
hsa-miR-210-3p Testosterone+Tamoxifen resistant cell line (MCF-7)
hsa-miR-210-3p Osimertinib 71496458 NSC779217 approved sensitive cell line (H1975)
hsa-miR-210-3p Methotrexate 126941 NSC740 approved resistant cell line (HT29)
hsa-miR-210-3p Fluorouracil 3385 NSC19893 approved resistant cell line (KM12C) (72 h)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved resistant cell line (RPMI2650)
hsa-miR-210-3p Sunitinib 5329102 NSC750690 approved resistant tissue (CardA)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved resistant cell line (SKOV3)
hsa-miR-210-3p Platinum 23939 resistant tissue (non-small cell lung cancer)
hsa-miR-210-3p Tamoxifen 2733525 NSC180973 approved resistant cell line (TamR4)
hsa-miR-210-3p Tamoxifen 2733525 NSC180973 approved resistant cell line (TamR8)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive cell line (PC3PR20)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive cell line (PC3PR200)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive cell line (PC3PR70)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved resistant cell line (LM16)
hsa-miR-210-3p Bortezomib 387447 NSC681239 approved sensitive cell line (CCRF-CEM) (100 nM)
hsa-miR-210-3p Bortezomib 387447 NSC681239 approved sensitive cell line (CCRF-CEM) (200 nM)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved sensitive cell line (PANC-1) (100 ng/ml)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved sensitive cell line (PANC-1) (1500 ng/ml)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved sensitive cell line (Panc1-GR1)
hsa-miR-210-3p Ceritinib 57379345 NSC776422 approved resistant cell line (H3122)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved resistant cell line (H23)
hsa-miR-210-3p Cetuximab sensitive tissue (colorectal carcinoma)

Error report submission